Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 256
- +5 vs. Q1 2026
- Shares held
- 47.3M
- +4.42M (+10.3%) vs. Q1 2026
- Total value
- $2.98B
- −$30.9M (−1.0%) vs. Q1 2026
- New holders
- 39
- 103 more added
- Sold out
- 34
- 85 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cormorant Asset Management, LP | 100,000 | $6.29M | 0.32% | −125,000−55.6% | Reduced |
| Woodline Partners LP | 100,443 | $6.32M | 0.02% | 00.0% | Unchanged |
| Wells Fargo & Company | 111,639 | $7.03M | 0.00% | +22,346+25.0% | Added |
| Bank of New York Mellon Corp | 114,458 | $7.20M | 0.00% | +7,676+7.2% | Added |
| Qube Research & Technologies Ltd | 116,363 | $7.32M | 0.01% | −207,651−64.1% | Reduced |
| First Trust Advisors LP | 117,811 | $7.42M | 0.00% | −5,100−4.1% | Reduced |
| Jefferies Financial Group Inc. | 118,810 | $7.48M | 0.07% | 00.0% | Unchanged |
| Caption Management, LLC | 120,700 | $7.60M | 0.27% | +84,252+231.2% | Added |
| Seven Fleet Capital Management LP | 117,067 | $7.91M | 1.31% | +97,267+491.2% | Added |
| Allspring Global Investments Holdings, LLC | 130,329 | $7.94M | 0.01% | −1,283−1.0% | Reduced |
| JPMorgan Chase & Co | 139,981 | $8.68M | 0.00% | +109,503+359.3% | Added |
| Parkman Healthcare Partners LLC | 150,000 | $9.44M | 0.97% | +150,000 | New |
| Mackenzie Financial Corp | 191,428 | $12.0M | 0.01% | +191,428 | New |
| BNP Paribas Arbitrage, SA | 201,624 | $12.7M | 0.01% | −101,885−33.6% | Reduced |
| Citadel Advisors LLC | 241,737 | $15.2M | 0.01% | +77,740+47.4% | Added |
| Price T Rowe Associates Inc | 260,784 | $16.4M | 0.00% | −14,020−5.1% | Reduced |
| Ensign Peak Advisors, Inc | 268,696 | $16.9M | 0.03% | −64,286−19.3% | Reduced |
| Rock Springs Capital Management LP | 277,087 | $17.4M | 0.85% | +51,908+23.1% | Added |
| Artisan Partners Limited Partnership | 284,899 | $17.9M | 0.03% | −22,408−7.3% | Reduced |
| Franklin Resources Inc | 286,008 | $18.0M | 0.00% | −47,668−14.3% | Reduced |
| Vanguard Fiduciary Trust Co | 286,289 | $18.0M | 0.00% | +13,546+5.0% | Added |
| Squarepoint Ops LLC | 295,824 | $18.6M | 0.04% | +54,791+22.7% | Added |
| Driehaus Capital Management LLC | 317,576 | $20.0M | 0.12% | −608,549−65.7% | Reduced |
| MPM Oncology Impact Management LP | 322,007 | $20.3M | 1.24% | −7,743−2.3% | Reduced |
| Tri Locum Partners LP | 328,340 | $20.7M | 2.54% | +75,752+30.0% | Added |
| Charles Schwab Investment Management Inc | 335,834 | $21.1M | 0.00% | +7,672+2.3% | Added |
| Wasatch Advisors Inc | 368,568 | $23.2M | 0.15% | +368,568 | New |
| TimesSquare Capital Management, LLC | 369,377 | $23.2M | 0.34% | −19,213−4.9% | Reduced |
| Loomis Sayles & Co L P | 380,684 | $24.0M | 0.03% | −27,152−6.7% | Reduced |
| Vanguard Portfolio Management LLC | 385,137 | $24.2M | 0.00% | +49,248+14.7% | Added |
| Northern Trust Corp | 386,611 | $24.3M | 0.00% | +33,654+9.5% | Added |
| Massachusetts Financial Services Co | 427,008 | $26.9M | 0.01% | +427,008 | New |
| Lord, Abbett & Co. LLC | 479,266 | $30.2M | 0.09% | −363,047−43.1% | Reduced |
| Toronto Dominion Bank | 510,253 | $32.1M | 0.05% | 00.0% | Unchanged |
| Clearbridge Investments, LLC | 549,387 | $34.6M | 0.03% | +4,036+0.7% | Added |
| Nomura Asset Management International Inc. | 607,272 | $38.2M | 0.06% | +107,419+21.5% | Added |
| FMR LLC | 672,949 | $42.4M | 0.00% | −60,385−8.2% | Reduced |
| D. E. Shaw & Co., Inc. | 710,559 | $44.7M | 0.03% | −80,587−10.2% | Reduced |
| Frazier Life Sciences Management, L.P. | 728,644 | $45.9M | 1.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 742,693 | $46.7M | 0.00% | +303,067+68.9% | Added |
| Invesco Ltd. | 785,808 | $49.5M | 0.00% | +43,311+5.8% | Added |
| Assenagon Asset Management S.A. | 947,495 | $59.6M | 0.08% | −332,699−26.0% | Reduced |
| Vestal Point Capital, LP | 1,050,000 | $66.1M | 1.54% | +850,000+425.0% | Added |
| State Street Corp | 1,072,951 | $67.5M | 0.00% | +94,739+9.7% | Added |
| Geode Capital Management, LLC | 1,105,689 | $69.6M | 0.00% | −15,402−1.4% | Reduced |
| Bank of America Corp | 1,193,182 | $75.1M | 0.00% | −1,195−0.1% | Reduced |
| Millennium Management LLC | 1,427,124 | $89.8M | 0.06% | +862,545+152.8% | Added |
| Tang Capital Management LLC | 1,568,266 | $98.7M | 4.48% | +379,642+31.9% | Added |
| Jennison Associates LLC | 1,663,655 | $104.7M | 0.06% | −48,469−2.8% | Reduced |
| Vanguard Capital Management LLC | 1,793,064 | $112.9M | 0.00% | +32,523+1.8% | Added |
| Morgan Stanley | 1,827,082 | $115.0M | 0.01% | −117,190−6.0% | Reduced |
| Paradigm Biocapital Advisors LP | 2,775,649 | $174.7M | 3.27% | +213,495+8.3% | Added |
| Jupiter Topco LLC | 2,808,796 | $176.8M | 0.07% | +2,808,796 | New |
| RTW Investments, LP | 3,357,059 | $211.3M | 1.80% | +11,034+0.3% | Added |
| Deep Track Capital, LP | 3,666,768 | $230.8M | 3.40% | +66,768+1.9% | Added |
| BlackRock, Inc. | 3,856,137 | $242.7M | 0.00% | +303,525+8.5% | Added |
| Braidwell LP | 0 | $0 | 0.00% | −265,715−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −226,251−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| M&G Plc | 0 | $0 | 0.00% | −166,364−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −80,859−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −47,600−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −43,832−100.0% | Sold out |
| GordonMD Global Investments LP | 0 | $0 | 0.00% | −42,680−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −41,815−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −34,685−100.0% | Sold out |
| Public Sector Pension Investment Board | 0 | $0 | 0.00% | −32,000−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −31,760−100.0% | Sold out |
| Capricorn Fund Managers Ltd | 0 | $0 | 0.00% | −26,000−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −25,942−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −23,252−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −15,163−100.0% | Sold out |
| Zacks Investment Management | 0 | $0 | 0.00% | −14,879−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −9,465−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −6,556−100.0% | Sold out |
| Verdad Advisers, LP | 0 | $0 | 0.00% | −6,328−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −4,600−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −4,322−100.0% | Sold out |
| Guggenheim Capital LLC | 0 | $0 | 0.00% | −3,688−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −3,287−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −3,035−100.0% | Sold out |
| Antipodes Partners Ltd | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −299−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| LRI Investments, LLC | 0 | $0 | 0.00% | −41−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −36−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Cullen/Frost Bankers, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |